On the occasion of the World Osteoporosis Day which takes place every year on October 20th, Gnosis has participated at the special event "Supplements in the non-pharmacologic treatment of osteoporosis” with a speech held by Dr. Luca Tiano - presenting new highlights and evidence of the use of vitamin K2 menaquinone-7 in the form of vitaMK7® and K2&Olive™.
The importance of the consumption of folate to support the body's well-being is now widely recognized and folate definitely represents one of the most common nutritional ingredients used during all stages of life.
Enthusiastic feed-back of nutraceutical industry at VENDORBRIEF presentation of Mythocondro® held last week during Supply Side West, in Las Vegas.
We are pleased to announce our presence at the Infant Nutrition 2016 online event which will take place on October 18, 2016.
Blis Technologies and Stratum Nutrition announce a new clinical study on the effects of oral-cavity probiotic, BLIS K12® (Streptococcus salivarius K12), on the reduction of halitosis in children.
Supply Side West is approaching and Gnosis will be protagonist with the launch of Mythocondro®, the first Non-Animal Chondroitin sulfate of fermentation origin, that promises to change completely the CS industry.
Ever wondered why you may be feeling tired? You could be suffering from a lack of Ubiquinol in the body. Ubiquinol provides every cell in the body with energy so that it can function and is also a powerful antioxidant.
French supplier FYTEXIA will kick-off SupplySide West 2016 with a Grand Opening ceremony built around the release of an entirely new line of branded, clinically proven ingredients for sports nutrition.
Stratum Nutrition and joint-venture partner, ESM Technologies, the manufacturer of innovative, commercialized eggshell and eggshell membrane wellness ingredients, are pleased to announce a new canine study has published in the journal, Veterinary Medicine: Research & Reports, evaluating their joint health ingredient, NEM® brand eggshell membrane.
Chemi Nutra announces the filing of a novel patent related to its proprietary AlphaSize® Alpha-Glyceryl Phosphoryl Choline (A-GPC) and its use in replacing, displacing, or augmenting caffeine and providing superior physiological benefits, without caffeine’s detrimental mental and physical effects.